跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,652 条关于
“β3 adrenergic receptors”
全部
5,652
临床试验
3,515
药物
673
机构
7
资讯
1,457
2年前
FDA Accepts Sumitomo Pharma's sNDA for Vibegron in Men with OAB and BPH
去年
Vibegron Shows Sustained Long-Term Safety and Efficacy for Men with OAB and BPH
去年
Eisai Launches Beova Tablets for Overactive Bladder Treatment in Thailand
11个月前
MSN Labs Receives Regulatory Approval for Phase III Trial of Vibegron 75 mg in Overactive Bladder
16年前
Urovant Sciences Launches GEMTESA® (vibegron) for Overactive Bladder Treatment in the U.S.
去年
NMDA Receptor Research Reveals Novel Mechanism for Brain Stabilization and Potential Depression Treatments
去年
Zydus Healthcare to Conduct Phase III Trial for Glycopyrrolate/Indacaterol Inhaler
去年
Duke University Develops SBI-810, Novel Non-Opioid Painkiller Targeting Specific Brain Receptors
3个月前
Mystery Gene Glo1 Reveals Novel Anxiety Mechanism via Methylglyoxal and GABA-A Receptors
去年
Vanda Pharmaceuticals Submits NDA for Novel Antipsychotic Bysanti to Treat Bipolar I Disorder and Schizophrenia
第 1 页,共 146 页
上一页
下一页